JPMorgan raises target for Givaudan stock from CHF 3,700 to CHF 4,100

Published on 10/16/2026 at 09:20 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Nine-month sales grew 5.20 percent to CHF 5,891 million. Givaudan stock costs EUR 4,231.50 on October 16, 2026 beside a CHF 36.2 billion value.

Analyst view and operating growth

JPMorgan set a CHF 4,100.00 target on October 14, 2026.
Givaudan recorded CHF 5,891 million in nine-month sales with 5.20 percent like-for-like growth.
Givaudan stock trades at EUR 4,231.50 at 9:13 a.m. CEST at Lang & Schwarz on October 16, 2026.
Market capitalization stood at CHF 36.2 billion as of October 16, 2026.

A Bauhaus-inspired graphic poster illustration. A large undulating wave in bold primary red, cobalt blue, and golden yellow sweeps across a cream-white grid background. Small geometric molecule dot clusters and hexagonal molecular shapes float along the w — Givaudan CH0010645932 Bauhaus-Plakat mit geometrischer Duftstoff-Welle und Molekülpunkten in Primärfarben und Lavendel, Illustration mit AI erstellt.

JPMorgan raised its price target for Givaudan stock from CHF 3,700.00 to CHF 4,100.00 while retaining an Overweight rating, according to Markets Insider on October 14, 2026. The move followed Givaudan's stronger-than-expected third-quarter sales update.

Analysts raise targets after sales growth

Givaudan reported CHF 5,891 million in sales for the first nine months of 2026, up 5.20 percent on a like-for-like basis and 2.60 percent in Swiss francs from the prior-year period, according to its Givaudan release dated October 13, 2026. Fragrance and Beauty generated CHF 3,150 million, up 8.80 percent like-for-like, while Taste and Wellbeing reached CHF 2,741 million and declined 2.80 percent in Swiss francs.

The quarterly figures also exceeded the company-compiled view. MarketScreener reported third-quarter sales of CHF 2,090 million, up 11.00 percent year over year, against consensus of CHF 1,990 million. Like-for-like growth was 8.60 percent against an expected 4.70 percent.

What do the targets mean for valuation?

The analyst picture remains divided even after the sales acceleration. Deutsche Bank raised its target from CHF 3,700.00 to CHF 4,100.00 and kept Buy, while Bernstein lifted its target from CHF 2,886.00 to CHF 3,004.00 and retained Underperform, as reported by FinanzNachrichten on October 13, 2026. The spread reflects stronger fragrance demand alongside continuing caution about the food ingredients division.

Three dated developments

On October 13, 2026, Givaudan reported CHF 5,891 million in nine-month sales. On October 14, 2026, JPMorgan raised its target to CHF 4,100.00. On October 14, 2026, Deutsche Bank also set a CHF 4,100.00 target, according to the linked analyst coverage.

Dates for the calendar

Givaudan's investor page lists a presentation in Zurich for October 29, 2026 and full-year results for January 27, 2027, according to Givaudan.

Stock price and market value

Givaudan has a market capitalization of CHF 36.2 billion as of October 16, 2026. Its 52-week range is CHF 2,566.00 to CHF 3,948.00 on the SIX Swiss Exchange, placing the Swiss quotation near its upper end. At Lang & Schwarz, the stock was trading at EUR 4,231.50 on October 16, 2026 at 9:13 a.m. CEST.

The further course of trading is shown by the continuously updated real-time quote of Givaudan stock.